Penumbra 

$320.00
53
+$0.00+0% Friday 01:41

統計

當日最高
320
當日最低
320
52週高點
334.23
52週低點
313.05
成交量
11
平均成交量
-
市值
12.59B
本益比
-
股息殖利率
-
股息
-

即將到來

財報

4Aug預期
Q3 2025
Q1 2026
下一步
0.82
0.93
1.05
1.16
預期EPS
1.159048
實際EPS
不適用

財務

12.66%利潤率
有盈利
2020
2021
2022
2023
2024
2025
1.4B營收
177.69M淨利

分析師評級

363.70平均目標價
最高預估為 374.00。
來自過去6個月內的 12 則評分。這不是投資建議。
買入
8%
持有
92%
賣出
0%

其他人也在關注

此清單是根據在 Stock Events 上追蹤 PEN.BOATS 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.
Show more...
執行長
Mr. Adam Elsesser J.D.
員工
4700
國家
美國
ISIN
US70975L1070

上市

0 Comments

分享你的想法

FAQ

Penumbra 今天的股價是多少?
PEN.BOATS 目前價格為 $320.00 USD,過去 24 小時上漲了 +0%。在圖表上更密切關注 Penumbra 股價表現。
Penumbra 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Penumbra 的股票以代號 PEN.BOATS 進行交易。
Penumbra 的市值是多少?
今天 Penumbra 的市值為 12.59B
Penumbra 下一次財報日期是什麼時候?
Penumbra 將於 August 04, 2026 公布下一次財報。
Penumbra 上一季度的財報如何?
PEN.BOATS 上一季度的財報為每股 0.82 USD,預估為 1.04 USD,帶來 -21.02% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Penumbra 去年的營收是多少?
Penumbra 去年的營收為 1.4BUSD。
Penumbra 去年的淨利是多少?
PEN.BOATS 去年的淨收益為 177.69MUSD。
Penumbra 有多少名員工?
截至 July 06, 2026,公司共有 4,700 名員工。
Penumbra 位於哪個產業?
Penumbra從事於Health & Wellness產業。
Penumbra 何時完成拆股?
Penumbra 最近沒有進行任何拆股。
Penumbra 的總部在哪裡?
Penumbra 的總部位於 美國 的 Alameda。